CHAMPIONS ONCOLOGY, INC. Quarterly Common Stock, Shares, Issued from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Champions Oncology, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q1 2011 to Q2 2024.
  • Champions Oncology, Inc. Common Stock, Shares, Issued for the quarter ending July 31, 2024 was 13.7M shares, a 0.84% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 13.7M +115K +0.84% Jul 31, 2024 10-Q 2024-09-13
Q1 2024 13.7M +120K +0.89% Apr 30, 2024 10-Q 2024-09-13
Q4 2023 13.7M +155K +1.15% Jan 31, 2024 10-Q 2024-03-15
Q3 2023 13.7M +155K +1.15% Oct 31, 2023 10-Q 2023-12-13
Q2 2023 13.6M +77.1K +0.57% Jul 31, 2023 10-Q 2023-09-13
Q1 2023 13.6M +71.3K +0.53% Apr 30, 2023 10-K 2024-07-19
Q4 2022 13.6M +40.7K +0.3% Jan 31, 2023 10-Q 2023-03-16
Q3 2022 13.6M +62.5K +0.46% Oct 31, 2022 10-Q 2022-12-13
Q2 2022 13.5M +107K +0.8% Jul 31, 2022 10-Q 2022-09-12
Q1 2022 13.5M +108K +0.81% Apr 30, 2022 10-K 2023-07-24
Q4 2021 13.5M +128K +0.95% Jan 31, 2022 10-Q 2022-03-15
Q3 2021 13.5M +128K +0.95% Oct 31, 2021 10-Q 2021-12-13
Q2 2021 13.4M +687K +5.4% Jul 31, 2021 10-Q 2021-09-13
Q1 2021 13.4M +687K +5.4% Apr 30, 2021 10-K 2022-07-22
Q4 2020 13.4M +1.57M +13.3% Jan 31, 2021 10-Q 2021-03-15
Q3 2020 13.4M +1.75M +15% Oct 31, 2020 10-Q 2020-12-14
Q2 2020 12.7M +1.11M +9.54% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 12.7M +1.11M +9.53% Apr 30, 2020 10-K 2021-07-26
Q4 2019 11.8M +211K +1.81% Jan 31, 2020 10-Q 2020-03-16
Q3 2019 11.6M +145K +1.27% Oct 31, 2019 10-Q 2019-12-16
Q2 2019 11.6M +322K +2.85% Jul 31, 2019 10-Q 2019-09-16
Q1 2019 11.6M +342K +3.03% Apr 30, 2019 10-K 2020-07-28
Q4 2018 11.6M +335K +2.97% Jan 31, 2019 10-Q 2019-03-18
Q3 2018 11.5M +210K +1.86% Oct 31, 2018 10-Q 2018-12-17
Q2 2018 11.3M +45.8K +0.41% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 11.3M +25.8K +0.23% Apr 30, 2018 10-K 2019-07-29
Q4 2017 11.3M +37.3K +0.33% Jan 31, 2018 10-Q 2018-03-19
Q3 2017 11.3M +28K +0.25% Oct 31, 2017 10-Q 2017-12-15
Q2 2017 11.3M +14.7K +0.13% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 11.3M +2.28M +25.4% Apr 30, 2017 10-K 2018-07-30
Q4 2016 11.2M +2.28M +25.4% Jan 31, 2017 10-Q 2017-03-17
Q3 2016 11.2M +2.27M +25.4% Oct 31, 2016 10-Q 2016-12-14
Q2 2016 11.2M +2.27M +25.4% Jul 31, 2016 10-Q 2016-09-14
Q1 2016 8.97M +12.2K +0.14% Apr 30, 2016 10-K 2017-07-28
Q4 2015 8.96M -61.2M -87.2% Jan 31, 2016 10-Q 2016-03-16
Q3 2015 8.96M -61.2M -87.2% Oct 31, 2015 10-Q 2015-12-15
Q2 2015 8.96M -61.2M -87.2% Jul 31, 2015 10-Q 2015-09-11
Q1 2015 8.96M -61.2M -87.2% Apr 30, 2015 10-K 2016-07-29
Q4 2014 70.1M +22.5K +0.03% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 70.1M +31.2M +79.9% Oct 31, 2014 10-Q 2014-12-15
Q2 2014 70.1M +31.2M +80% Jul 31, 2014 10-Q 2014-09-12
Q1 2014 70.1M +31.3M +80.5% Apr 30, 2014 10-K 2015-07-29
Q4 2013 70.1M +31.2M +80.4% Jan 31, 2014 10-Q 2014-03-14
Q3 2013 39M +1.23M +3.26% Oct 31, 2013 10-Q 2013-12-13
Q2 2013 39M +1.21M +3.22% Jul 31, 2013 10-Q 2013-09-13
Q1 2013 38.9M +1.11M +2.95% Apr 30, 2013 10-K 2014-07-28
Q4 2012 38.9M +1.4M +3.75% Jan 31, 2013 10-Q 2013-03-13
Q3 2012 37.7M +289K +0.77% Oct 31, 2012 10-Q 2012-12-13
Q2 2012 37.7M +769K +2.08% Jul 31, 2012 10-Q 2012-09-12
Q1 2012 37.7M +784K +2.12% Apr 30, 2012 10-K 2013-07-26
Q4 2011 37.5M Jan 31, 2012 10-Q 2012-03-14
Q3 2011 37.5M Oct 31, 2011 10-Q 2011-12-14
Q2 2011 37M Jul 31, 2011 10-Q 2011-09-13
Q1 2011 37M Apr 30, 2011 10-K 2012-07-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.